Jenan Al-Matouq

Dedicated assistant professor with a proven track record in delivering exceptional education for undergraduates. Recognized for implementing innovative teaching methods that foster critical thinking and consistently result in positive student evaluations. A prolific researcher, contributing numerous publications to reputable journals, advancing the field of cancer biology and biomedical sciences. Committed to excellence, demonstrating comprehensive leadership in academia.

• Al-Matouq, J. (2024). Advances in Skin Cancer. IntechOpen.
• Alqurain AA, Albaharnah M, Al Zayer S, Ameer L, Ghosn S, Al-Shaibi S, Algoraini M, Aldhafeeri A, Alyusuf DA, Alshnbari A, Alsaffar N, AlMatouq J, Al Khamees M, AlAlwan B and Alomar FA (2024) The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi Arabia: a cross-sectional study. Front. Pharmacol.
• Ameer, L., Aslam, N., Ghosn, S., Al-Matouq, J., Al-Mousa, Z., Alasfour, S., Suroor, M., & Amin, Y. H. (2024). Establishing competency based internship program through participatory action research in a private pharmacy college in the Eastern Province of Saudi Arabia. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 32(3), 101983.
• Ali, M. D., Al-Matouq, J. A., Ahmad, A., Patel, M., Alshnbari, A. S., Alhussini, S. H., Almozien, S. F., Alowaywi, G. A., & Kannan, L. S. (2024). Survival after Trastuzumab Therapy in Patients with Locally Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of Randomized Controlled Trials. Journal of pharmacy & bioallied sciences, 16(1), 24–30.
• Eman M Gaber Hassan, Latha S Kannan, Amal Al Suliman, Sharell Lewis, Hanan Al Majed, Suad Al Abdullatif, Shainy Daniel, & Jenan A. Al Matouq. (2024). Enhancing Academic Monitoring: Examining The Correlation Between The Results Of Progress Test And The Cumulative Grade Point Averages Of Nursing Students. Educational Administration: Theory and Practice, 30(5), 7703–7710.
• Rabaan, A. A., Bukhamsin, R., AlSaihati, H., Alshamrani, S. A., AlSihati, J., Al-Afghani, H. M., Alsubki, R. A., Abuzaid, A. A., Al-Abdulhadi, S., Aldawood, Y., Alsaleh, A. A., Alhashem, Y. N., Almatouq, J. A., Emran, T. B., Al-Ahmed, S. H., Nainu, F., & Mohapatra, R. K. (2022). Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics. Molecules (Basel, Switzerland), 27(24), 8659.
• Al-Matouq, J. A., Ali, M. D., Al-Somali, S. M., Ahmad, A., Banu, N., & Patel, M. (2022). Prevalence of side-effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia. Infection prevention in practice, 4(4), 100251.
• Sarah A. Albasha, Manar Z. Almotawa, Abdulmonem A. Alsaleh, Noura N. Alibrahim, Zaheda H. Radwan, Yousef N. Alhashem, Jenan Almatouq and Mariam K. Alamoudi. In Silico Analysis of DNA Methylation Status of T-Cell Inflamed Signature Reveals a Therapeutic Strategy to Improve Immune Checkpoint Inhibitors Efficacy in Wilms Tumor. Journal of Pharmacology and Experimental Therapeutics June 1, 2023, 385 (S3) 236;
• Manar Z. Almotawa, Sarah A. Albasha, Abdulmonem A. Alsaleh, Noura N. Alibrahim, Zaheda H. Radwan, Yousef N. Alhashem, Jenan Almatouq and Mariam K. Alamoudi. Targeting Epigenetic Modification of T-Cell Inflamed Signature to Enhance Immune Checkpoint Inhibitors Response in Small Cell Lung Cancer. Journal of Pharmacology and Experimental Therapeutics June 1, 2023, 385 (S3) 435.
• Sarah A. Albasha, Manar Z. Almotawa, Abdulmonem A. Alsaleh, Noura N. Alibrahim, Mariam K. Alamoudi, Zahiah F. Al Mohsen, Yahya Aldawood, Hayyan A. Al-Taweil, Fatimah J. Al Shaikh and Jenan Almatouq. Examining the DNA Methylation Profile of Childhood Solid Tumors to Identify Novel Therapeutically Targeted Sites. Journal of Pharmacology and Experimental Therapeutics June 1, 2023, 385 (S3) 438.
• Sibai, M. T., Alabdullaziz , F., & Al-Matouq, J. A. (2023). The Impact of Workload on Faculty Performance: Implications for Policy Revision. A Study of a Private Medical College in Saudi Arabia. Advances in Social Sciences Research Journal, 10(3), 219–228.
• Rabaan, A. A., Bakhrebah, M. A., AlSaihati, H., Alhumaid, S., Alsubki, R. A., Turkistani, S. A., Al-Abdulhadi, S., Aldawood, Y., Alsaleh, A. A., Alhashem, Y. N., Almatouq, J. A., Alqatari, A. A., Alahmed, H. E., Sharbini, D. A., Alahmadi, A. F., Alsalman, F., Alsayyah, A., & Mutair, A. A. (2022). Artificial Intelligence for Clinical Diagnosis and Treatment of Prostate Cancer. Cancers, 14(22), 5595.
• Al-Matouq, J., Al-Haj, L., Al-Saif, M. et al. Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway. Oncogenesis 10, 61 (2021).
• Holmes, T. R., Al-Matouq, J., Holmes, M., Sioda, N., Nicola, L., Rudd, Bloom, C., Palermo, N., Madson, J., Lovas, S., & Hansen, L. A. (2020) Targeting 14-3-3ε activates apoptotic signaling to prevent cutaneous squamous cell carcinoma, Carcinogenesis, 2020
• Holmes, T. R., Al-Matouq, J., Holmes, M., Nicola, L., Rudd, J. C., Lovas, S., & Hansen, L. A. (2020). Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer. Oncotarget, 11(35), 3267–3278.
• Al-Matouq, J., Holmes, T. R., & Hansen, L. A. (2019). CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death. Molecular carcinogenesis, 58(9), 1691–1700.
• Al-matouq, J.A, Holmes, T., Hansen, L.A (2017) Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25Afor cancer cell survival and tumor growth. Cancer letters. Vol. 410; 41-49.
• Alyusuf R.H, Al-matouq, JA, Taha, S, Wazir, J.F (2013) The pattern of expressionand role of Triiodothyronine (T3) receptors and type 1 5’- Deiodinase in breast carcinomas, benign breast diseases, lactational change, and normal breast epithelium. Applied Immunohistochem Mol Morphology . Vol. 22; 7; 518-524.
• Yanagida, J, Hammiller, B, Almatouq, J. A., Hansen, L (2012). Accelerated elimination of ultraviolet-induced DNA damage through apoptosis in CDC25A- deficient skin. Carcinogenesis. 33:9.
• Jenan Almatouq, Kristen Ho, Laura A. Hansen; Abstract 1310: Increased cytoplasmic CDC25A phosphatase in cutaneous squamous cell carcinoma leads to 14-3-3 relocalization and suppression of apoptosis. Cancer Res 1 October 2014; 74 (19_Supplement): 1310.
• Almatouq, J.A. (2014). Role of CDC25 Phosphatases in Non-Melanoma Skin Cancer. Creighton University proquest dissertations.

• The International Meeting on Simulation in Healthcare (IMSH), January 2024, San Diego
• Global Medical Biotechnology Summit. Riyadh, 25-26 Jan, 2023
• 5th Saudi Health Simulation Conference. November 2022, Riyadh
• Quality assurance standards, indicators and benchmarking, ETEC, December 6-7
• Saudi Society for Simulation Scientific Assembly
• Introduction to data Science for education evaluation, ETEC, October, 2020
• Assessment of Program learning, October 13, 2020, ETEC
• The international Conference on Education and training evaluation, October 2020, ETEC
• Mobile summer institute for Scientific Teaching, University of Oregon, 2016 and University of Olympia, WA, 2018
• English for specific courses- Health Sciences, Oregon University, 2017
• Essential Skills in Health Professions Education (ESHPE) on Course Design, IAU 21-23December 2015.
• Attended Breakthroughs in Basic and Translational Cancer research conference, American Association of Cancer Research (AACR), Maui, HI, USA. Feb. 21-25, 2013
• Attended American Society for Microbiology- Missouri Valley Branch conference NE, USA. April 11, 2011.
• Attended the International Symposium on Biotechnology, Sfax, Tunisia. May 4-8, 2008
• Attended “The 1st Pan Arab Human Genetics Conference”, Center for Arab Genomic Studies, Dubai, United Arab Emirates. 5-6 April, 2006
• Attended the “6th Saudi School in Human Molecular Genetics”, King Saud University,Riyadh, KSA. 13-18 March, 2004
• Attended the “Gene Cloning and DNA Analysis Workshop”, Arabian Gulf University,Kingdom of Bahrain. 4-8 October 2003
• Attended a workshop on “Molecular Diagnosis of Beta Thalassemia”, King Fahd University Hospital, KSA. 9 December, 2003
• Attended “Stop TB” Seminar and workshop, SAMSO, Aramco, KSA. March, 2002

• Saudi Commission License - Consultant, 04KT2989

• Academic Quality Reviewer Certificate, ETEC, November 2021

• CPD Champions Certificate Program, Accreditation Council for Continuing Medical Education, September 2021- March 2022.

• Academic Quality Practitioner Certificate, ETEC, June 23, 2021

• Certified Item writer by Saudi Commission for health specialties, 2019

• Reviewer of the Prometric exam developed for clinical lab science, Saudi Commission for Health specialties. 2018

• Scientific Teaching Facilitator, Yale center for teaching and learning , mobile institute held in University of Olympia, WA, 2018.

• Scientific Teaching Fellow, Yale center for teaching and learning , mobile institute held in University of Oregon, 2016